The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

High-dose HCQ use may lower the risk for diabetes among patients with pSS and can potentially mitigate the diabetogenic effects of glucocorticoids.

Early-life risk factors including lack of breastfeeding and low birth weight were associated with increased risk for adult-onset type 2 diabetes.

Adiposity mediated the association between increased insulin resistance and cardiac damage among adolescents and young adults.

AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine ...

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

A new White House report says today’s children are the sickest generation in U.S. history when it comes to chronic disease.

For patients with acute ischemic stroke, IV tenecteplase before endovascular thrombectomy is associated with higher functional independence at 90 days.

A discussion about screening for Lp(a), a factor that can contribute to hypertension, with Wenjun Fan, MD, PhD, and Arya ...

The US Food and Drug Administration has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines.

In adults with nonalcoholic fatty liver disease and obesity, the estimated glucose disposal rate strongly negatively correlated with liver fibrosis severity.